nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—UGT2B7—urinary bladder cancer	0.219	0.472	CbGaD
Ibuprofen—CXCL8—urinary bladder cancer	0.124	0.266	CbGaD
Ibuprofen—PPARG—urinary bladder cancer	0.0854	0.184	CbGaD
Ibuprofen—PTGS2—urinary bladder cancer	0.0361	0.0777	CbGaD
Ibuprofen—UGT2B7—Epirubicin—urinary bladder cancer	0.0287	0.101	CbGbCtD
Ibuprofen—ABCC4—Fluorouracil—urinary bladder cancer	0.0237	0.0832	CbGbCtD
Ibuprofen—ABCC1—Epirubicin—urinary bladder cancer	0.0204	0.0716	CbGbCtD
Ibuprofen—UGT1A1—Etoposide—urinary bladder cancer	0.0193	0.0679	CbGbCtD
Ibuprofen—ABCB1—Mitomycin—urinary bladder cancer	0.0186	0.0655	CbGbCtD
Ibuprofen—ABCC1—Etoposide—urinary bladder cancer	0.0159	0.0558	CbGbCtD
Ibuprofen—SLC22A11—Methotrexate—urinary bladder cancer	0.014	0.0493	CbGbCtD
Ibuprofen—ABCC4—Methotrexate—urinary bladder cancer	0.0131	0.0459	CbGbCtD
Ibuprofen—CFTR—vas deferens—urinary bladder cancer	0.0121	0.202	CbGeAlD
Ibuprofen—PTGS2—Cisplatin—urinary bladder cancer	0.0118	0.0416	CbGbCtD
Ibuprofen—PTGS2—Etoposide—urinary bladder cancer	0.0116	0.0408	CbGbCtD
Ibuprofen—ABCC1—Doxorubicin—urinary bladder cancer	0.0108	0.0381	CbGbCtD
Ibuprofen—ABCC1—Methotrexate—urinary bladder cancer	0.0105	0.0369	CbGbCtD
Ibuprofen—PTGS1—Etoposide—urinary bladder cancer	0.00981	0.0345	CbGbCtD
Ibuprofen—SLCO1A2—Methotrexate—urinary bladder cancer	0.00937	0.0329	CbGbCtD
Ibuprofen—ALB—Fluorouracil—urinary bladder cancer	0.00878	0.0309	CbGbCtD
Ibuprofen—SLC22A8—Methotrexate—urinary bladder cancer	0.00816	0.0287	CbGbCtD
Ibuprofen—CYP2C8—Fluorouracil—urinary bladder cancer	0.00678	0.0238	CbGbCtD
Ibuprofen—SLC22A6—Methotrexate—urinary bladder cancer	0.00568	0.02	CbGbCtD
Ibuprofen—CYP2C8—Etoposide—urinary bladder cancer	0.00566	0.0199	CbGbCtD
Ibuprofen—ABCB1—Gemcitabine—urinary bladder cancer	0.00537	0.0189	CbGbCtD
Ibuprofen—ALB—Methotrexate—urinary bladder cancer	0.00484	0.017	CbGbCtD
Ibuprofen—CYP2C9—Fluorouracil—urinary bladder cancer	0.00473	0.0166	CbGbCtD
Ibuprofen—CYP2C9—Cisplatin—urinary bladder cancer	0.00402	0.0141	CbGbCtD
Ibuprofen—ABCB1—Cisplatin—urinary bladder cancer	0.0039	0.0137	CbGbCtD
Ibuprofen—ABCB1—Etoposide—urinary bladder cancer	0.00383	0.0135	CbGbCtD
Ibuprofen—ABCB1—Doxorubicin—urinary bladder cancer	0.00261	0.00919	CbGbCtD
Ibuprofen—ABCB1—Methotrexate—urinary bladder cancer	0.00253	0.0089	CbGbCtD
Ibuprofen—UGT1A1—urine—urinary bladder cancer	0.00199	0.0332	CbGeAlD
Ibuprofen—FABP2—epithelium—urinary bladder cancer	0.00174	0.029	CbGeAlD
Ibuprofen—THBD—prostate gland—urinary bladder cancer	0.00152	0.0252	CbGeAlD
Ibuprofen—SLC22A8—urine—urinary bladder cancer	0.00129	0.0214	CbGeAlD
Ibuprofen—THBD—epithelium—urinary bladder cancer	0.00112	0.0185	CbGeAlD
Ibuprofen—CFTR—prostate gland—urinary bladder cancer	0.00108	0.018	CbGeAlD
Ibuprofen—CYP2C19—urine—urinary bladder cancer	0.00108	0.018	CbGeAlD
Ibuprofen—THBD—smooth muscle tissue—urinary bladder cancer	0.00107	0.0179	CbGeAlD
Ibuprofen—PLAT—prostate gland—urinary bladder cancer	0.00107	0.0178	CbGeAlD
Ibuprofen—BCL2—prostate gland—urinary bladder cancer	0.00107	0.0178	CbGeAlD
Ibuprofen—THBD—renal system—urinary bladder cancer	0.00103	0.0172	CbGeAlD
Ibuprofen—THBD—urethra—urinary bladder cancer	0.00102	0.0169	CbGeAlD
Ibuprofen—CXCL8—prostate gland—urinary bladder cancer	0.00099	0.0165	CbGeAlD
Ibuprofen—PPARG—Teniposide—Etoposide—urinary bladder cancer	0.00099	1	CbGdCrCtD
Ibuprofen—CFTR—seminal vesicle—urinary bladder cancer	0.000916	0.0152	CbGeAlD
Ibuprofen—PLAT—seminal vesicle—urinary bladder cancer	0.000904	0.015	CbGeAlD
Ibuprofen—Suprofen—UGT2B7—urinary bladder cancer	0.000893	0.318	CrCbGaD
Ibuprofen—UGT2B7—prostate gland—urinary bladder cancer	0.000842	0.014	CbGeAlD
Ibuprofen—CYP2C9—urine—urinary bladder cancer	0.000838	0.0139	CbGeAlD
Ibuprofen—THBD—female reproductive system—urinary bladder cancer	0.000829	0.0138	CbGeAlD
Ibuprofen—CFTR—epithelium—urinary bladder cancer	0.000796	0.0132	CbGeAlD
Ibuprofen—BCL2—epithelium—urinary bladder cancer	0.000786	0.0131	CbGeAlD
Ibuprofen—FABP2—lymph node—urinary bladder cancer	0.000758	0.0126	CbGeAlD
Ibuprofen—BCL2—smooth muscle tissue—urinary bladder cancer	0.000757	0.0126	CbGeAlD
Ibuprofen—THBD—vagina—urinary bladder cancer	0.000749	0.0125	CbGeAlD
Ibuprofen—CFTR—renal system—urinary bladder cancer	0.000738	0.0123	CbGeAlD
Ibuprofen—BCL2—renal system—urinary bladder cancer	0.000729	0.0121	CbGeAlD
Ibuprofen—PLAT—urethra—urinary bladder cancer	0.000716	0.0119	CbGeAlD
Ibuprofen—UGT1A1—prostate gland—urinary bladder cancer	0.000716	0.0119	CbGeAlD
Ibuprofen—UGT1A9—renal system—urinary bladder cancer	0.000712	0.0118	CbGeAlD
Ibuprofen—CXCL8—smooth muscle tissue—urinary bladder cancer	0.000701	0.0117	CbGeAlD
Ibuprofen—Naproxen—UGT2B7—urinary bladder cancer	0.000701	0.25	CrCbGaD
Ibuprofen—CXCL8—urethra—urinary bladder cancer	0.000663	0.011	CbGeAlD
Ibuprofen—CFTR—female reproductive system—urinary bladder cancer	0.000591	0.00983	CbGeAlD
Ibuprofen—BCL2—female reproductive system—urinary bladder cancer	0.000584	0.00971	CbGeAlD
Ibuprofen—UGT2B7—renal system—urinary bladder cancer	0.000574	0.00954	CbGeAlD
Ibuprofen—SLC22A11—renal system—urinary bladder cancer	0.000559	0.0093	CbGeAlD
Ibuprofen—PLAT—vagina—urinary bladder cancer	0.000528	0.00878	CbGeAlD
Ibuprofen—SLCO2B1—prostate gland—urinary bladder cancer	0.000527	0.00876	CbGeAlD
Ibuprofen—PPARG—prostate gland—urinary bladder cancer	0.000514	0.00854	CbGeAlD
Ibuprofen—Flurbiprofen—UGT2B7—urinary bladder cancer	0.000502	0.179	CrCbGaD
Ibuprofen—CXCL8—vagina—urinary bladder cancer	0.000489	0.00813	CbGeAlD
Ibuprofen—UGT1A1—renal system—urinary bladder cancer	0.000488	0.00811	CbGeAlD
Ibuprofen—THBD—lymph node—urinary bladder cancer	0.000485	0.00806	CbGeAlD
Ibuprofen—ABCC4—prostate gland—urinary bladder cancer	0.000467	0.00776	CbGeAlD
Ibuprofen—SLC22A8—prostate gland—urinary bladder cancer	0.000463	0.0077	CbGeAlD
Ibuprofen—UGT2B7—female reproductive system—urinary bladder cancer	0.00046	0.00764	CbGeAlD
Ibuprofen—SLC22A11—female reproductive system—urinary bladder cancer	0.000448	0.00745	CbGeAlD
Ibuprofen—ABCC1—prostate gland—urinary bladder cancer	0.000398	0.00661	CbGeAlD
Ibuprofen—PPARG—epithelium—urinary bladder cancer	0.000378	0.00628	CbGeAlD
Ibuprofen—PPARG—smooth muscle tissue—urinary bladder cancer	0.000364	0.00605	CbGeAlD
Ibuprofen—SLCO2B1—renal system—urinary bladder cancer	0.000359	0.00597	CbGeAlD
Ibuprofen—PPARG—renal system—urinary bladder cancer	0.00035	0.00582	CbGeAlD
Ibuprofen—PPARG—urethra—urinary bladder cancer	0.000344	0.00572	CbGeAlD
Ibuprofen—BCL2—lymph node—urinary bladder cancer	0.000341	0.00568	CbGeAlD
Ibuprofen—PLAT—lymph node—urinary bladder cancer	0.000341	0.00568	CbGeAlD
Ibuprofen—ABCC1—seminal vesicle—urinary bladder cancer	0.000336	0.00559	CbGeAlD
Ibuprofen—SLCO1A2—renal system—urinary bladder cancer	0.00033	0.00549	CbGeAlD
Ibuprofen—ABCC4—renal system—urinary bladder cancer	0.000318	0.00529	CbGeAlD
Ibuprofen—CXCL8—lymph node—urinary bladder cancer	0.000316	0.00526	CbGeAlD
Ibuprofen—SLC22A8—renal system—urinary bladder cancer	0.000315	0.00525	CbGeAlD
Ibuprofen—SLCO2B1—female reproductive system—urinary bladder cancer	0.000288	0.00478	CbGeAlD
Ibuprofen—PPARG—female reproductive system—urinary bladder cancer	0.00028	0.00466	CbGeAlD
Ibuprofen—PTGS1—prostate gland—urinary bladder cancer	0.000275	0.00457	CbGeAlD
Ibuprofen—ABCC1—urethra—urinary bladder cancer	0.000266	0.00443	CbGeAlD
Ibuprofen—PTGS2—prostate gland—urinary bladder cancer	0.000263	0.00437	CbGeAlD
Ibuprofen—ABCC4—female reproductive system—urinary bladder cancer	0.000255	0.00423	CbGeAlD
Ibuprofen—PPARG—vagina—urinary bladder cancer	0.000254	0.00422	CbGeAlD
Ibuprofen—Carprofen—PTGS2—urinary bladder cancer	0.000238	0.0849	CrCbGaD
Ibuprofen—PTGS1—seminal vesicle—urinary bladder cancer	0.000232	0.00386	CbGeAlD
Ibuprofen—CYP2C8—renal system—urinary bladder cancer	0.000231	0.00384	CbGeAlD
Ibuprofen—PTGS2—seminal vesicle—urinary bladder cancer	0.000222	0.00369	CbGeAlD
Ibuprofen—PTGS1—epithelium—urinary bladder cancer	0.000202	0.00336	CbGeAlD
Ibuprofen—ABCC1—vagina—urinary bladder cancer	0.000196	0.00327	CbGeAlD
Ibuprofen—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000194	0.00323	CbGeAlD
Ibuprofen—PTGS2—epithelium—urinary bladder cancer	0.000193	0.00321	CbGeAlD
Ibuprofen—CYP2C19—vagina—urinary bladder cancer	0.000192	0.00319	CbGeAlD
Ibuprofen—PTGS1—renal system—urinary bladder cancer	0.000187	0.00311	CbGeAlD
Ibuprofen—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000186	0.00309	CbGeAlD
Ibuprofen—CYP2C8—female reproductive system—urinary bladder cancer	0.000185	0.00307	CbGeAlD
Ibuprofen—PTGS2—renal system—urinary bladder cancer	0.000179	0.00298	CbGeAlD
Ibuprofen—PTGS2—urethra—urinary bladder cancer	0.000176	0.00292	CbGeAlD
Ibuprofen—SLCO2B1—lymph node—urinary bladder cancer	0.000168	0.0028	CbGeAlD
Ibuprofen—CYP2C8—vagina—urinary bladder cancer	0.000167	0.00278	CbGeAlD
Ibuprofen—CYP2C9—female reproductive system—urinary bladder cancer	0.000164	0.00273	CbGeAlD
Ibuprofen—PPARG—lymph node—urinary bladder cancer	0.000164	0.00273	CbGeAlD
Ibuprofen—ABCB1—prostate gland—urinary bladder cancer	0.000162	0.0027	CbGeAlD
Ibuprofen—ALB—lymph node—urinary bladder cancer	0.000154	0.00256	CbGeAlD
Ibuprofen—PTGS1—female reproductive system—urinary bladder cancer	0.00015	0.00249	CbGeAlD
Ibuprofen—ABCC4—lymph node—urinary bladder cancer	0.000149	0.00248	CbGeAlD
Ibuprofen—Suprofen—PTGS2—urinary bladder cancer	0.000147	0.0524	CrCbGaD
Ibuprofen—PTGS2—female reproductive system—urinary bladder cancer	0.000143	0.00238	CbGeAlD
Ibuprofen—ABCB1—seminal vesicle—urinary bladder cancer	0.000137	0.00228	CbGeAlD
Ibuprofen—PTGS1—vagina—urinary bladder cancer	0.000136	0.00225	CbGeAlD
Ibuprofen—PTGS2—vagina—urinary bladder cancer	0.00013	0.00216	CbGeAlD
Ibuprofen—ABCC1—lymph node—urinary bladder cancer	0.000127	0.00211	CbGeAlD
Ibuprofen—Fenoprofen—PTGS2—urinary bladder cancer	0.000127	0.0452	CrCbGaD
Ibuprofen—ABCB1—epithelium—urinary bladder cancer	0.000119	0.00198	CbGeAlD
Ibuprofen—Naproxen—PTGS2—urinary bladder cancer	0.000115	0.0412	CrCbGaD
Ibuprofen—ABCB1—renal system—urinary bladder cancer	0.000111	0.00184	CbGeAlD
Ibuprofen—ABCB1—urethra—urinary bladder cancer	0.000109	0.00181	CbGeAlD
Ibuprofen—ABCB1—female reproductive system—urinary bladder cancer	8.86e-05	0.00147	CbGeAlD
Ibuprofen—PTGS1—lymph node—urinary bladder cancer	8.77e-05	0.00146	CbGeAlD
Ibuprofen—PTGS2—lymph node—urinary bladder cancer	8.38e-05	0.00139	CbGeAlD
Ibuprofen—Flurbiprofen—PTGS2—urinary bladder cancer	8.28e-05	0.0295	CrCbGaD
Ibuprofen—ABCB1—vagina—urinary bladder cancer	8.02e-05	0.00133	CbGeAlD
Ibuprofen—ABCB1—lymph node—urinary bladder cancer	5.19e-05	0.000862	CbGeAlD
Ibuprofen—Haemoglobin—Epirubicin—urinary bladder cancer	4.29e-05	0.000438	CcSEcCtD
Ibuprofen—Stomatitis—Doxorubicin—urinary bladder cancer	4.29e-05	0.000438	CcSEcCtD
Ibuprofen—Jaundice—Doxorubicin—urinary bladder cancer	4.29e-05	0.000438	CcSEcCtD
Ibuprofen—Rhinitis—Epirubicin—urinary bladder cancer	4.28e-05	0.000437	CcSEcCtD
Ibuprofen—Abdominal pain—Etoposide—urinary bladder cancer	4.28e-05	0.000437	CcSEcCtD
Ibuprofen—Urinary tract infection—Doxorubicin—urinary bladder cancer	4.28e-05	0.000437	CcSEcCtD
Ibuprofen—Conjunctivitis—Doxorubicin—urinary bladder cancer	4.28e-05	0.000437	CcSEcCtD
Ibuprofen—Hepatitis—Epirubicin—urinary bladder cancer	4.27e-05	0.000436	CcSEcCtD
Ibuprofen—Haemorrhage—Epirubicin—urinary bladder cancer	4.27e-05	0.000436	CcSEcCtD
Ibuprofen—Diarrhoea—Fluorouracil—urinary bladder cancer	4.26e-05	0.000436	CcSEcCtD
Ibuprofen—Tinnitus—Methotrexate—urinary bladder cancer	4.25e-05	0.000435	CcSEcCtD
Ibuprofen—Asthenia—Cisplatin—urinary bladder cancer	4.24e-05	0.000433	CcSEcCtD
Ibuprofen—Pharyngitis—Epirubicin—urinary bladder cancer	4.24e-05	0.000433	CcSEcCtD
Ibuprofen—Sweating—Doxorubicin—urinary bladder cancer	4.22e-05	0.000431	CcSEcCtD
Ibuprofen—Urinary tract disorder—Epirubicin—urinary bladder cancer	4.21e-05	0.000431	CcSEcCtD
Ibuprofen—Oedema peripheral—Epirubicin—urinary bladder cancer	4.2e-05	0.00043	CcSEcCtD
Ibuprofen—Haematuria—Doxorubicin—urinary bladder cancer	4.19e-05	0.000429	CcSEcCtD
Ibuprofen—Urethral disorder—Epirubicin—urinary bladder cancer	4.18e-05	0.000428	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	4.16e-05	0.000425	CcSEcCtD
Ibuprofen—Epistaxis—Doxorubicin—urinary bladder cancer	4.15e-05	0.000424	CcSEcCtD
Ibuprofen—Sinusitis—Doxorubicin—urinary bladder cancer	4.13e-05	0.000422	CcSEcCtD
Ibuprofen—Immune system disorder—Methotrexate—urinary bladder cancer	4.12e-05	0.000421	CcSEcCtD
Ibuprofen—Dizziness—Fluorouracil—urinary bladder cancer	4.12e-05	0.000421	CcSEcCtD
Ibuprofen—Visual impairment—Epirubicin—urinary bladder cancer	4.11e-05	0.00042	CcSEcCtD
Ibuprofen—Mediastinal disorder—Methotrexate—urinary bladder cancer	4.11e-05	0.00042	CcSEcCtD
Ibuprofen—Agranulocytosis—Doxorubicin—urinary bladder cancer	4.11e-05	0.00042	CcSEcCtD
Ibuprofen—Chills—Methotrexate—urinary bladder cancer	4.09e-05	0.000418	CcSEcCtD
Ibuprofen—Diarrhoea—Cisplatin—urinary bladder cancer	4.04e-05	0.000413	CcSEcCtD
Ibuprofen—Erythema multiforme—Epirubicin—urinary bladder cancer	4.04e-05	0.000412	CcSEcCtD
Ibuprofen—Alopecia—Methotrexate—urinary bladder cancer	4.03e-05	0.000412	CcSEcCtD
Ibuprofen—Vomiting—Gemcitabine—urinary bladder cancer	4.03e-05	0.000412	CcSEcCtD
Ibuprofen—Mental disorder—Methotrexate—urinary bladder cancer	4e-05	0.000408	CcSEcCtD
Ibuprofen—Rash—Gemcitabine—urinary bladder cancer	3.99e-05	0.000408	CcSEcCtD
Ibuprofen—Dermatitis—Gemcitabine—urinary bladder cancer	3.99e-05	0.000408	CcSEcCtD
Ibuprofen—Hypersensitivity—Etoposide—urinary bladder cancer	3.99e-05	0.000407	CcSEcCtD
Ibuprofen—Tinnitus—Epirubicin—urinary bladder cancer	3.98e-05	0.000407	CcSEcCtD
Ibuprofen—Malnutrition—Methotrexate—urinary bladder cancer	3.97e-05	0.000406	CcSEcCtD
Ibuprofen—Erythema—Methotrexate—urinary bladder cancer	3.97e-05	0.000406	CcSEcCtD
Ibuprofen—Haemoglobin—Doxorubicin—urinary bladder cancer	3.97e-05	0.000406	CcSEcCtD
Ibuprofen—Headache—Gemcitabine—urinary bladder cancer	3.97e-05	0.000406	CcSEcCtD
Ibuprofen—Vomiting—Fluorouracil—urinary bladder cancer	3.96e-05	0.000405	CcSEcCtD
Ibuprofen—Rhinitis—Doxorubicin—urinary bladder cancer	3.96e-05	0.000405	CcSEcCtD
Ibuprofen—Haemorrhage—Doxorubicin—urinary bladder cancer	3.95e-05	0.000404	CcSEcCtD
Ibuprofen—Hepatitis—Doxorubicin—urinary bladder cancer	3.95e-05	0.000404	CcSEcCtD
Ibuprofen—Rash—Fluorouracil—urinary bladder cancer	3.93e-05	0.000401	CcSEcCtD
Ibuprofen—Dermatitis—Fluorouracil—urinary bladder cancer	3.92e-05	0.000401	CcSEcCtD
Ibuprofen—Pharyngitis—Doxorubicin—urinary bladder cancer	3.92e-05	0.000401	CcSEcCtD
Ibuprofen—Headache—Fluorouracil—urinary bladder cancer	3.9e-05	0.000399	CcSEcCtD
Ibuprofen—Urinary tract disorder—Doxorubicin—urinary bladder cancer	3.9e-05	0.000399	CcSEcCtD
Ibuprofen—Oedema peripheral—Doxorubicin—urinary bladder cancer	3.89e-05	0.000398	CcSEcCtD
Ibuprofen—Dysgeusia—Methotrexate—urinary bladder cancer	3.89e-05	0.000397	CcSEcCtD
Ibuprofen—Asthenia—Etoposide—urinary bladder cancer	3.88e-05	0.000397	CcSEcCtD
Ibuprofen—Urethral disorder—Doxorubicin—urinary bladder cancer	3.87e-05	0.000396	CcSEcCtD
Ibuprofen—Immune system disorder—Epirubicin—urinary bladder cancer	3.85e-05	0.000394	CcSEcCtD
Ibuprofen—Mediastinal disorder—Epirubicin—urinary bladder cancer	3.85e-05	0.000393	CcSEcCtD
Ibuprofen—Chills—Epirubicin—urinary bladder cancer	3.83e-05	0.000391	CcSEcCtD
Ibuprofen—Pruritus—Etoposide—urinary bladder cancer	3.83e-05	0.000391	CcSEcCtD
Ibuprofen—Arrhythmia—Epirubicin—urinary bladder cancer	3.81e-05	0.00039	CcSEcCtD
Ibuprofen—Visual impairment—Doxorubicin—urinary bladder cancer	3.81e-05	0.000389	CcSEcCtD
Ibuprofen—Alopecia—Epirubicin—urinary bladder cancer	3.77e-05	0.000385	CcSEcCtD
Ibuprofen—Nausea—Gemcitabine—urinary bladder cancer	3.76e-05	0.000385	CcSEcCtD
Ibuprofen—Vomiting—Cisplatin—urinary bladder cancer	3.75e-05	0.000384	CcSEcCtD
Ibuprofen—Vision blurred—Methotrexate—urinary bladder cancer	3.74e-05	0.000382	CcSEcCtD
Ibuprofen—Mental disorder—Epirubicin—urinary bladder cancer	3.74e-05	0.000382	CcSEcCtD
Ibuprofen—Erythema multiforme—Doxorubicin—urinary bladder cancer	3.73e-05	0.000382	CcSEcCtD
Ibuprofen—Rash—Cisplatin—urinary bladder cancer	3.72e-05	0.00038	CcSEcCtD
Ibuprofen—Dermatitis—Cisplatin—urinary bladder cancer	3.72e-05	0.00038	CcSEcCtD
Ibuprofen—Malnutrition—Epirubicin—urinary bladder cancer	3.72e-05	0.00038	CcSEcCtD
Ibuprofen—Erythema—Epirubicin—urinary bladder cancer	3.72e-05	0.00038	CcSEcCtD
Ibuprofen—Diarrhoea—Etoposide—urinary bladder cancer	3.7e-05	0.000378	CcSEcCtD
Ibuprofen—Nausea—Fluorouracil—urinary bladder cancer	3.7e-05	0.000378	CcSEcCtD
Ibuprofen—Ill-defined disorder—Methotrexate—urinary bladder cancer	3.68e-05	0.000376	CcSEcCtD
Ibuprofen—Tinnitus—Doxorubicin—urinary bladder cancer	3.68e-05	0.000376	CcSEcCtD
Ibuprofen—Anaemia—Methotrexate—urinary bladder cancer	3.67e-05	0.000375	CcSEcCtD
Ibuprofen—Flatulence—Epirubicin—urinary bladder cancer	3.66e-05	0.000374	CcSEcCtD
Ibuprofen—Tension—Epirubicin—urinary bladder cancer	3.65e-05	0.000373	CcSEcCtD
Ibuprofen—Dysgeusia—Epirubicin—urinary bladder cancer	3.64e-05	0.000372	CcSEcCtD
Ibuprofen—Nervousness—Epirubicin—urinary bladder cancer	3.61e-05	0.000369	CcSEcCtD
Ibuprofen—Malaise—Methotrexate—urinary bladder cancer	3.58e-05	0.000366	CcSEcCtD
Ibuprofen—Dizziness—Etoposide—urinary bladder cancer	3.58e-05	0.000366	CcSEcCtD
Ibuprofen—Muscle spasms—Epirubicin—urinary bladder cancer	3.57e-05	0.000365	CcSEcCtD
Ibuprofen—Immune system disorder—Doxorubicin—urinary bladder cancer	3.57e-05	0.000365	CcSEcCtD
Ibuprofen—Vertigo—Methotrexate—urinary bladder cancer	3.57e-05	0.000365	CcSEcCtD
Ibuprofen—Mediastinal disorder—Doxorubicin—urinary bladder cancer	3.56e-05	0.000364	CcSEcCtD
Ibuprofen—Leukopenia—Methotrexate—urinary bladder cancer	3.55e-05	0.000363	CcSEcCtD
Ibuprofen—Chills—Doxorubicin—urinary bladder cancer	3.54e-05	0.000362	CcSEcCtD
Ibuprofen—Arrhythmia—Doxorubicin—urinary bladder cancer	3.53e-05	0.000361	CcSEcCtD
Ibuprofen—Nausea—Cisplatin—urinary bladder cancer	3.51e-05	0.000358	CcSEcCtD
Ibuprofen—Vision blurred—Epirubicin—urinary bladder cancer	3.5e-05	0.000358	CcSEcCtD
Ibuprofen—Alopecia—Doxorubicin—urinary bladder cancer	3.49e-05	0.000357	CcSEcCtD
Ibuprofen—Cough—Methotrexate—urinary bladder cancer	3.46e-05	0.000354	CcSEcCtD
Ibuprofen—Mental disorder—Doxorubicin—urinary bladder cancer	3.46e-05	0.000354	CcSEcCtD
Ibuprofen—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.45e-05	0.000352	CcSEcCtD
Ibuprofen—Convulsion—Methotrexate—urinary bladder cancer	3.44e-05	0.000352	CcSEcCtD
Ibuprofen—Vomiting—Etoposide—urinary bladder cancer	3.44e-05	0.000351	CcSEcCtD
Ibuprofen—Malnutrition—Doxorubicin—urinary bladder cancer	3.44e-05	0.000351	CcSEcCtD
Ibuprofen—Erythema—Doxorubicin—urinary bladder cancer	3.44e-05	0.000351	CcSEcCtD
Ibuprofen—Anaemia—Epirubicin—urinary bladder cancer	3.43e-05	0.000351	CcSEcCtD
Ibuprofen—Agitation—Epirubicin—urinary bladder cancer	3.41e-05	0.000349	CcSEcCtD
Ibuprofen—Rash—Etoposide—urinary bladder cancer	3.41e-05	0.000349	CcSEcCtD
Ibuprofen—Dermatitis—Etoposide—urinary bladder cancer	3.41e-05	0.000348	CcSEcCtD
Ibuprofen—Headache—Etoposide—urinary bladder cancer	3.39e-05	0.000346	CcSEcCtD
Ibuprofen—Flatulence—Doxorubicin—urinary bladder cancer	3.39e-05	0.000346	CcSEcCtD
Ibuprofen—Myalgia—Methotrexate—urinary bladder cancer	3.38e-05	0.000345	CcSEcCtD
Ibuprofen—Arthralgia—Methotrexate—urinary bladder cancer	3.38e-05	0.000345	CcSEcCtD
Ibuprofen—Tension—Doxorubicin—urinary bladder cancer	3.37e-05	0.000345	CcSEcCtD
Ibuprofen—Dysgeusia—Doxorubicin—urinary bladder cancer	3.37e-05	0.000344	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.36e-05	0.000343	CcSEcCtD
Ibuprofen—Malaise—Epirubicin—urinary bladder cancer	3.35e-05	0.000342	CcSEcCtD
Ibuprofen—Discomfort—Methotrexate—urinary bladder cancer	3.34e-05	0.000341	CcSEcCtD
Ibuprofen—Nervousness—Doxorubicin—urinary bladder cancer	3.34e-05	0.000341	CcSEcCtD
Ibuprofen—Vertigo—Epirubicin—urinary bladder cancer	3.34e-05	0.000341	CcSEcCtD
Ibuprofen—Syncope—Epirubicin—urinary bladder cancer	3.33e-05	0.000341	CcSEcCtD
Ibuprofen—Leukopenia—Epirubicin—urinary bladder cancer	3.33e-05	0.00034	CcSEcCtD
Ibuprofen—Muscle spasms—Doxorubicin—urinary bladder cancer	3.31e-05	0.000338	CcSEcCtD
Ibuprofen—Palpitations—Epirubicin—urinary bladder cancer	3.28e-05	0.000336	CcSEcCtD
Ibuprofen—Confusional state—Methotrexate—urinary bladder cancer	3.27e-05	0.000334	CcSEcCtD
Ibuprofen—Loss of consciousness—Epirubicin—urinary bladder cancer	3.27e-05	0.000334	CcSEcCtD
Ibuprofen—Cough—Epirubicin—urinary bladder cancer	3.24e-05	0.000331	CcSEcCtD
Ibuprofen—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.24e-05	0.000331	CcSEcCtD
Ibuprofen—Vision blurred—Doxorubicin—urinary bladder cancer	3.24e-05	0.000331	CcSEcCtD
Ibuprofen—Convulsion—Epirubicin—urinary bladder cancer	3.22e-05	0.000329	CcSEcCtD
Ibuprofen—Infection—Methotrexate—urinary bladder cancer	3.22e-05	0.000329	CcSEcCtD
Ibuprofen—Nausea—Etoposide—urinary bladder cancer	3.21e-05	0.000328	CcSEcCtD
Ibuprofen—Hypertension—Epirubicin—urinary bladder cancer	3.21e-05	0.000328	CcSEcCtD
Ibuprofen—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.19e-05	0.000326	CcSEcCtD
Ibuprofen—Nervous system disorder—Methotrexate—urinary bladder cancer	3.18e-05	0.000325	CcSEcCtD
Ibuprofen—Anaemia—Doxorubicin—urinary bladder cancer	3.18e-05	0.000325	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.17e-05	0.000324	CcSEcCtD
Ibuprofen—Arthralgia—Epirubicin—urinary bladder cancer	3.16e-05	0.000323	CcSEcCtD
Ibuprofen—Myalgia—Epirubicin—urinary bladder cancer	3.16e-05	0.000323	CcSEcCtD
Ibuprofen—Agitation—Doxorubicin—urinary bladder cancer	3.16e-05	0.000323	CcSEcCtD
Ibuprofen—Anxiety—Epirubicin—urinary bladder cancer	3.15e-05	0.000322	CcSEcCtD
Ibuprofen—Skin disorder—Methotrexate—urinary bladder cancer	3.15e-05	0.000322	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.14e-05	0.000321	CcSEcCtD
Ibuprofen—Hyperhidrosis—Methotrexate—urinary bladder cancer	3.13e-05	0.00032	CcSEcCtD
Ibuprofen—Discomfort—Epirubicin—urinary bladder cancer	3.13e-05	0.000319	CcSEcCtD
Ibuprofen—Malaise—Doxorubicin—urinary bladder cancer	3.1e-05	0.000317	CcSEcCtD
Ibuprofen—Dry mouth—Epirubicin—urinary bladder cancer	3.09e-05	0.000316	CcSEcCtD
Ibuprofen—Vertigo—Doxorubicin—urinary bladder cancer	3.09e-05	0.000316	CcSEcCtD
Ibuprofen—Anorexia—Methotrexate—urinary bladder cancer	3.09e-05	0.000316	CcSEcCtD
Ibuprofen—Syncope—Doxorubicin—urinary bladder cancer	3.08e-05	0.000315	CcSEcCtD
Ibuprofen—Leukopenia—Doxorubicin—urinary bladder cancer	3.08e-05	0.000314	CcSEcCtD
Ibuprofen—Confusional state—Epirubicin—urinary bladder cancer	3.06e-05	0.000312	CcSEcCtD
Ibuprofen—Palpitations—Doxorubicin—urinary bladder cancer	3.04e-05	0.00031	CcSEcCtD
Ibuprofen—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.03e-05	0.00031	CcSEcCtD
Ibuprofen—Oedema—Epirubicin—urinary bladder cancer	3.03e-05	0.00031	CcSEcCtD
Ibuprofen—Hypotension—Methotrexate—urinary bladder cancer	3.03e-05	0.000309	CcSEcCtD
Ibuprofen—Loss of consciousness—Doxorubicin—urinary bladder cancer	3.02e-05	0.000309	CcSEcCtD
Ibuprofen—Infection—Epirubicin—urinary bladder cancer	3.01e-05	0.000308	CcSEcCtD
Ibuprofen—Cough—Doxorubicin—urinary bladder cancer	3e-05	0.000307	CcSEcCtD
Ibuprofen—Shock—Epirubicin—urinary bladder cancer	2.98e-05	0.000305	CcSEcCtD
Ibuprofen—Convulsion—Doxorubicin—urinary bladder cancer	2.98e-05	0.000304	CcSEcCtD
Ibuprofen—Nervous system disorder—Epirubicin—urinary bladder cancer	2.97e-05	0.000304	CcSEcCtD
Ibuprofen—Thrombocytopenia—Epirubicin—urinary bladder cancer	2.97e-05	0.000303	CcSEcCtD
Ibuprofen—Hypertension—Doxorubicin—urinary bladder cancer	2.97e-05	0.000303	CcSEcCtD
Ibuprofen—Tachycardia—Epirubicin—urinary bladder cancer	2.96e-05	0.000302	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	2.95e-05	0.000302	CcSEcCtD
Ibuprofen—Skin disorder—Epirubicin—urinary bladder cancer	2.95e-05	0.000301	CcSEcCtD
Ibuprofen—Hyperhidrosis—Epirubicin—urinary bladder cancer	2.93e-05	0.0003	CcSEcCtD
Ibuprofen—Insomnia—Methotrexate—urinary bladder cancer	2.93e-05	0.000299	CcSEcCtD
Ibuprofen—Myalgia—Doxorubicin—urinary bladder cancer	2.93e-05	0.000299	CcSEcCtD
Ibuprofen—Arthralgia—Doxorubicin—urinary bladder cancer	2.93e-05	0.000299	CcSEcCtD
Ibuprofen—Anxiety—Doxorubicin—urinary bladder cancer	2.92e-05	0.000298	CcSEcCtD
Ibuprofen—Paraesthesia—Methotrexate—urinary bladder cancer	2.91e-05	0.000297	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	2.91e-05	0.000297	CcSEcCtD
Ibuprofen—Discomfort—Doxorubicin—urinary bladder cancer	2.89e-05	0.000296	CcSEcCtD
Ibuprofen—Anorexia—Epirubicin—urinary bladder cancer	2.89e-05	0.000295	CcSEcCtD
Ibuprofen—Dyspnoea—Methotrexate—urinary bladder cancer	2.89e-05	0.000295	CcSEcCtD
Ibuprofen—Somnolence—Methotrexate—urinary bladder cancer	2.88e-05	0.000294	CcSEcCtD
Ibuprofen—Dry mouth—Doxorubicin—urinary bladder cancer	2.86e-05	0.000293	CcSEcCtD
Ibuprofen—Dyspepsia—Methotrexate—urinary bladder cancer	2.85e-05	0.000291	CcSEcCtD
Ibuprofen—Hypotension—Epirubicin—urinary bladder cancer	2.83e-05	0.00029	CcSEcCtD
Ibuprofen—Confusional state—Doxorubicin—urinary bladder cancer	2.83e-05	0.000289	CcSEcCtD
Ibuprofen—Decreased appetite—Methotrexate—urinary bladder cancer	2.82e-05	0.000288	CcSEcCtD
Ibuprofen—Anaphylactic shock—Doxorubicin—urinary bladder cancer	2.81e-05	0.000287	CcSEcCtD
Ibuprofen—Oedema—Doxorubicin—urinary bladder cancer	2.81e-05	0.000287	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	2.8e-05	0.000286	CcSEcCtD
Ibuprofen—Fatigue—Methotrexate—urinary bladder cancer	2.79e-05	0.000285	CcSEcCtD
Ibuprofen—Infection—Doxorubicin—urinary bladder cancer	2.79e-05	0.000285	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	2.76e-05	0.000282	CcSEcCtD
Ibuprofen—Shock—Doxorubicin—urinary bladder cancer	2.76e-05	0.000282	CcSEcCtD
Ibuprofen—Nervous system disorder—Doxorubicin—urinary bladder cancer	2.75e-05	0.000281	CcSEcCtD
Ibuprofen—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.75e-05	0.000281	CcSEcCtD
Ibuprofen—Insomnia—Epirubicin—urinary bladder cancer	2.74e-05	0.00028	CcSEcCtD
Ibuprofen—Tachycardia—Doxorubicin—urinary bladder cancer	2.74e-05	0.00028	CcSEcCtD
Ibuprofen—Skin disorder—Doxorubicin—urinary bladder cancer	2.73e-05	0.000279	CcSEcCtD
Ibuprofen—Paraesthesia—Epirubicin—urinary bladder cancer	2.72e-05	0.000278	CcSEcCtD
Ibuprofen—Hyperhidrosis—Doxorubicin—urinary bladder cancer	2.71e-05	0.000277	CcSEcCtD
Ibuprofen—Dyspnoea—Epirubicin—urinary bladder cancer	2.7e-05	0.000276	CcSEcCtD
Ibuprofen—Somnolence—Epirubicin—urinary bladder cancer	2.7e-05	0.000275	CcSEcCtD
Ibuprofen—Anorexia—Doxorubicin—urinary bladder cancer	2.67e-05	0.000273	CcSEcCtD
Ibuprofen—Feeling abnormal—Methotrexate—urinary bladder cancer	2.67e-05	0.000273	CcSEcCtD
Ibuprofen—Dyspepsia—Epirubicin—urinary bladder cancer	2.67e-05	0.000273	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.65e-05	0.000271	CcSEcCtD
Ibuprofen—Decreased appetite—Epirubicin—urinary bladder cancer	2.64e-05	0.000269	CcSEcCtD
Ibuprofen—Hypotension—Doxorubicin—urinary bladder cancer	2.62e-05	0.000268	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.62e-05	0.000268	CcSEcCtD
Ibuprofen—Fatigue—Epirubicin—urinary bladder cancer	2.61e-05	0.000267	CcSEcCtD
Ibuprofen—Constipation—Epirubicin—urinary bladder cancer	2.59e-05	0.000265	CcSEcCtD
Ibuprofen—Urticaria—Methotrexate—urinary bladder cancer	2.57e-05	0.000263	CcSEcCtD
Ibuprofen—Abdominal pain—Methotrexate—urinary bladder cancer	2.56e-05	0.000262	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.56e-05	0.000261	CcSEcCtD
Ibuprofen—Insomnia—Doxorubicin—urinary bladder cancer	2.54e-05	0.000259	CcSEcCtD
Ibuprofen—Paraesthesia—Doxorubicin—urinary bladder cancer	2.52e-05	0.000257	CcSEcCtD
Ibuprofen—Dyspnoea—Doxorubicin—urinary bladder cancer	2.5e-05	0.000256	CcSEcCtD
Ibuprofen—Feeling abnormal—Epirubicin—urinary bladder cancer	2.5e-05	0.000255	CcSEcCtD
Ibuprofen—Somnolence—Doxorubicin—urinary bladder cancer	2.49e-05	0.000255	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.48e-05	0.000253	CcSEcCtD
Ibuprofen—Dyspepsia—Doxorubicin—urinary bladder cancer	2.47e-05	0.000252	CcSEcCtD
Ibuprofen—Decreased appetite—Doxorubicin—urinary bladder cancer	2.44e-05	0.000249	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.42e-05	0.000248	CcSEcCtD
Ibuprofen—Fatigue—Doxorubicin—urinary bladder cancer	2.42e-05	0.000247	CcSEcCtD
Ibuprofen—Urticaria—Epirubicin—urinary bladder cancer	2.41e-05	0.000246	CcSEcCtD
Ibuprofen—Constipation—Doxorubicin—urinary bladder cancer	2.4e-05	0.000245	CcSEcCtD
Ibuprofen—Abdominal pain—Epirubicin—urinary bladder cancer	2.4e-05	0.000245	CcSEcCtD
Ibuprofen—Hypersensitivity—Methotrexate—urinary bladder cancer	2.39e-05	0.000244	CcSEcCtD
Ibuprofen—Asthenia—Methotrexate—urinary bladder cancer	2.32e-05	0.000238	CcSEcCtD
Ibuprofen—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.31e-05	0.000236	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.29e-05	0.000234	CcSEcCtD
Ibuprofen—Pruritus—Methotrexate—urinary bladder cancer	2.29e-05	0.000234	CcSEcCtD
Ibuprofen—Hypersensitivity—Epirubicin—urinary bladder cancer	2.23e-05	0.000228	CcSEcCtD
Ibuprofen—Urticaria—Doxorubicin—urinary bladder cancer	2.23e-05	0.000228	CcSEcCtD
Ibuprofen—Abdominal pain—Doxorubicin—urinary bladder cancer	2.22e-05	0.000227	CcSEcCtD
Ibuprofen—Diarrhoea—Methotrexate—urinary bladder cancer	2.22e-05	0.000227	CcSEcCtD
Ibuprofen—Asthenia—Epirubicin—urinary bladder cancer	2.18e-05	0.000222	CcSEcCtD
Ibuprofen—Pruritus—Epirubicin—urinary bladder cancer	2.15e-05	0.000219	CcSEcCtD
Ibuprofen—Dizziness—Methotrexate—urinary bladder cancer	2.14e-05	0.000219	CcSEcCtD
Ibuprofen—Diarrhoea—Epirubicin—urinary bladder cancer	2.07e-05	0.000212	CcSEcCtD
Ibuprofen—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.07e-05	0.000211	CcSEcCtD
Ibuprofen—Vomiting—Methotrexate—urinary bladder cancer	2.06e-05	0.000211	CcSEcCtD
Ibuprofen—Rash—Methotrexate—urinary bladder cancer	2.04e-05	0.000209	CcSEcCtD
Ibuprofen—Dermatitis—Methotrexate—urinary bladder cancer	2.04e-05	0.000209	CcSEcCtD
Ibuprofen—Headache—Methotrexate—urinary bladder cancer	2.03e-05	0.000207	CcSEcCtD
Ibuprofen—Asthenia—Doxorubicin—urinary bladder cancer	2.01e-05	0.000206	CcSEcCtD
Ibuprofen—Dizziness—Epirubicin—urinary bladder cancer	2.01e-05	0.000205	CcSEcCtD
Ibuprofen—Pruritus—Doxorubicin—urinary bladder cancer	1.98e-05	0.000203	CcSEcCtD
Ibuprofen—Vomiting—Epirubicin—urinary bladder cancer	1.93e-05	0.000197	CcSEcCtD
Ibuprofen—Nausea—Methotrexate—urinary bladder cancer	1.92e-05	0.000197	CcSEcCtD
Ibuprofen—Diarrhoea—Doxorubicin—urinary bladder cancer	1.92e-05	0.000196	CcSEcCtD
Ibuprofen—Rash—Epirubicin—urinary bladder cancer	1.91e-05	0.000195	CcSEcCtD
Ibuprofen—Dermatitis—Epirubicin—urinary bladder cancer	1.91e-05	0.000195	CcSEcCtD
Ibuprofen—Headache—Epirubicin—urinary bladder cancer	1.9e-05	0.000194	CcSEcCtD
Ibuprofen—Dizziness—Doxorubicin—urinary bladder cancer	1.86e-05	0.00019	CcSEcCtD
Ibuprofen—Nausea—Epirubicin—urinary bladder cancer	1.8e-05	0.000184	CcSEcCtD
Ibuprofen—Vomiting—Doxorubicin—urinary bladder cancer	1.78e-05	0.000182	CcSEcCtD
Ibuprofen—Rash—Doxorubicin—urinary bladder cancer	1.77e-05	0.000181	CcSEcCtD
Ibuprofen—Dermatitis—Doxorubicin—urinary bladder cancer	1.77e-05	0.000181	CcSEcCtD
Ibuprofen—Headache—Doxorubicin—urinary bladder cancer	1.76e-05	0.00018	CcSEcCtD
Ibuprofen—Nausea—Doxorubicin—urinary bladder cancer	1.67e-05	0.00017	CcSEcCtD
Ibuprofen—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	4.48e-06	4.99e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—ERCC2—urinary bladder cancer	4.48e-06	4.99e-05	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—HRAS—urinary bladder cancer	4.48e-06	4.98e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.48e-06	4.98e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—EP300—urinary bladder cancer	4.45e-06	4.95e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.44e-06	4.94e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—FGFR3—urinary bladder cancer	4.44e-06	4.94e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—NAT2—urinary bladder cancer	4.43e-06	4.93e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—GPX1—urinary bladder cancer	4.4e-06	4.9e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.4e-06	4.89e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—RRM2—urinary bladder cancer	4.39e-06	4.88e-05	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—HRAS—urinary bladder cancer	4.37e-06	4.86e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—RRM2—urinary bladder cancer	4.36e-06	4.86e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—ERCC2—urinary bladder cancer	4.32e-06	4.81e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—SRC—urinary bladder cancer	4.32e-06	4.81e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.29e-06	4.77e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—CREBBP—urinary bladder cancer	4.24e-06	4.72e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—GSTP1—urinary bladder cancer	4.23e-06	4.71e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—MTHFR—urinary bladder cancer	4.22e-06	4.69e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	4.22e-06	4.69e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PPARG—urinary bladder cancer	4.21e-06	4.68e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IGF1—urinary bladder cancer	4.19e-06	4.66e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—MYC—urinary bladder cancer	4.17e-06	4.64e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—NAT2—urinary bladder cancer	4.14e-06	4.6e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.09e-06	4.55e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—EGFR—urinary bladder cancer	4.08e-06	4.54e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ENO2—urinary bladder cancer	4.07e-06	4.52e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	4.07e-06	4.52e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—MTHFR—urinary bladder cancer	4.06e-06	4.52e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CREBBP—urinary bladder cancer	4.06e-06	4.51e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—HPGDS—urinary bladder cancer	4.04e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ENO2—urinary bladder cancer	4.04e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.04e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	4.04e-06	4.5e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—NQO1—urinary bladder cancer	4.03e-06	4.48e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.02e-06	4.47e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IGF1—urinary bladder cancer	4.01e-06	4.46e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—EGFR—urinary bladder cancer	3.99e-06	4.43e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.95e-06	4.39e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	3.94e-06	4.39e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—TYMS—urinary bladder cancer	3.93e-06	4.38e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GSTT1—urinary bladder cancer	3.92e-06	4.36e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.92e-06	4.36e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	3.89e-06	4.33e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—NCOR1—urinary bladder cancer	3.89e-06	4.33e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—GSTM1—urinary bladder cancer	3.89e-06	4.33e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.88e-06	4.32e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.86e-06	4.29e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—KRAS—urinary bladder cancer	3.86e-06	4.29e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—RHOA—urinary bladder cancer	3.84e-06	4.27e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.82e-06	4.25e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—CREBBP—urinary bladder cancer	3.82e-06	4.25e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—EGFR—urinary bladder cancer	3.79e-06	4.22e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CREBBP—urinary bladder cancer	3.78e-06	4.21e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—KRAS—urinary bladder cancer	3.77e-06	4.19e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—GPX1—urinary bladder cancer	3.72e-06	4.14e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—NCOR1—urinary bladder cancer	3.69e-06	4.1e-05	CbGpPWpGaD
Ibuprofen—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.67e-06	4.08e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—RHOA—urinary bladder cancer	3.67e-06	4.08e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	3.66e-06	4.07e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—ERCC2—urinary bladder cancer	3.66e-06	4.07e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.63e-06	4.04e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.63e-06	4.04e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.61e-06	4.01e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—KRAS—urinary bladder cancer	3.58e-06	3.98e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.57e-06	3.97e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.54e-06	3.94e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.54e-06	3.94e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.52e-06	3.91e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	3.52e-06	3.91e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.47e-06	3.85e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—ERCC2—urinary bladder cancer	3.47e-06	3.85e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—MTHFR—urinary bladder cancer	3.44e-06	3.82e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.43e-06	3.82e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TP53—urinary bladder cancer	3.43e-06	3.81e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—RHOA—urinary bladder cancer	3.42e-06	3.8e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PPARG—urinary bladder cancer	3.42e-06	3.8e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PPARG—urinary bladder cancer	3.42e-06	3.8e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.41e-06	3.79e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—ERBB2—urinary bladder cancer	3.4e-06	3.78e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PTEN—urinary bladder cancer	3.39e-06	3.78e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—GSTP1—urinary bladder cancer	3.36e-06	3.74e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	3.31e-06	3.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.31e-06	3.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.31e-06	3.68e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PPARG—urinary bladder cancer	3.3e-06	3.67e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.29e-06	3.66e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—CREBBP—urinary bladder cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—HRAS—urinary bladder cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.28e-06	3.65e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—NQO1—urinary bladder cancer	3.26e-06	3.62e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MTHFR—urinary bladder cancer	3.26e-06	3.62e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.25e-06	3.61e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—TERT—urinary bladder cancer	3.25e-06	3.61e-05	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—EP300—urinary bladder cancer	3.24e-06	3.6e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IL2—urinary bladder cancer	3.22e-06	3.58e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.22e-06	3.58e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.21e-06	3.57e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—HRAS—urinary bladder cancer	3.2e-06	3.56e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.18e-06	3.54e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—CREBBP—urinary bladder cancer	3.17e-06	3.52e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—ERBB2—urinary bladder cancer	3.17e-06	3.52e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.16e-06	3.52e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.16e-06	3.51e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PTGS2—urinary bladder cancer	3.13e-06	3.48e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—TYMS—urinary bladder cancer	3.12e-06	3.47e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PTGS2—urinary bladder cancer	3.1e-06	3.44e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—NCOR1—urinary bladder cancer	3.09e-06	3.43e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—GSTM1—urinary bladder cancer	3.09e-06	3.43e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IL2—urinary bladder cancer	3.08e-06	3.42e-05	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HRAS—urinary bladder cancer	3.04e-06	3.39e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CCND1—urinary bladder cancer	3e-06	3.34e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—FGFR3—urinary bladder cancer	2.98e-06	3.32e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—GPX1—urinary bladder cancer	2.96e-06	3.29e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.92e-06	3.25e-05	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—MYC—urinary bladder cancer	2.92e-06	3.24e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MMP9—urinary bladder cancer	2.91e-06	3.24e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CDKN1A—urinary bladder cancer	2.9e-06	3.23e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ERCC2—urinary bladder cancer	2.9e-06	3.23e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PTEN—urinary bladder cancer	2.9e-06	3.22e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—EP300—urinary bladder cancer	2.89e-06	3.21e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PTEN—urinary bladder cancer	2.89e-06	3.21e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	2.88e-06	3.21e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.85e-06	3.18e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.84e-06	3.16e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—SRC—urinary bladder cancer	2.81e-06	3.12e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PPARG—urinary bladder cancer	2.79e-06	3.1e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.77e-06	3.08e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—EP300—urinary bladder cancer	2.76e-06	3.07e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.76e-06	3.07e-05	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—EP300—urinary bladder cancer	2.75e-06	3.06e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.73e-06	3.04e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PTEN—urinary bladder cancer	2.73e-06	3.04e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—MTHFR—urinary bladder cancer	2.73e-06	3.03e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GSTP1—urinary bladder cancer	2.72e-06	3.02e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—CDKN1A—urinary bladder cancer	2.71e-06	3.01e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PTEN—urinary bladder cancer	2.7e-06	3e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PTGS2—urinary bladder cancer	2.69e-06	2.99e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	2.69e-06	2.99e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—SRC—urinary bladder cancer	2.69e-06	2.99e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—CREBBP—urinary bladder cancer	2.68e-06	2.98e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.67e-06	2.97e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.64e-06	2.94e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.63e-06	2.92e-05	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—EP300—urinary bladder cancer	2.6e-06	2.89e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PTGS2—urinary bladder cancer	2.59e-06	2.88e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.59e-06	2.88e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—EP300—urinary bladder cancer	2.57e-06	2.86e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.54e-06	2.83e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CREBBP—urinary bladder cancer	2.54e-06	2.82e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—TYMS—urinary bladder cancer	2.53e-06	2.81e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	2.51e-06	2.8e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.51e-06	2.79e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.51e-06	2.79e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—SRC—urinary bladder cancer	2.5e-06	2.79e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GSTM1—urinary bladder cancer	2.5e-06	2.78e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—NCOR1—urinary bladder cancer	2.5e-06	2.78e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.47e-06	2.75e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.44e-06	2.71e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MYC—urinary bladder cancer	2.41e-06	2.68e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.4e-06	2.68e-05	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—EP300—urinary bladder cancer	2.4e-06	2.67e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—GPX1—urinary bladder cancer	2.39e-06	2.66e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.38e-06	2.65e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.36e-06	2.63e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.36e-06	2.63e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—EGFR—urinary bladder cancer	2.35e-06	2.62e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ERCC2—urinary bladder cancer	2.35e-06	2.61e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PTEN—urinary bladder cancer	2.34e-06	2.61e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PTEN—urinary bladder cancer	2.34e-06	2.61e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—KRAS—urinary bladder cancer	2.33e-06	2.59e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—RHOA—urinary bladder cancer	2.3e-06	2.55e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.27e-06	2.52e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PTEN—urinary bladder cancer	2.26e-06	2.52e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.26e-06	2.51e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—MYC—urinary bladder cancer	2.24e-06	2.5e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.24e-06	2.49e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.24e-06	2.49e-05	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—EP300—urinary bladder cancer	2.24e-06	2.49e-05	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—EP300—urinary bladder cancer	2.24e-06	2.49e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—KRAS—urinary bladder cancer	2.22e-06	2.47e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.22e-06	2.47e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.22e-06	2.47e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.21e-06	2.46e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PPARG—urinary bladder cancer	2.21e-06	2.46e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—MTHFR—urinary bladder cancer	2.21e-06	2.46e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—EGFR—urinary bladder cancer	2.19e-06	2.44e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PTGS2—urinary bladder cancer	2.19e-06	2.44e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.19e-06	2.43e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.19e-06	2.43e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—EP300—urinary bladder cancer	2.16e-06	2.4e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.15e-06	2.39e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.15e-06	2.39e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—CREBBP—urinary bladder cancer	2.12e-06	2.36e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—ERBB2—urinary bladder cancer	2.12e-06	2.36e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.11e-06	2.34e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.1e-06	2.33e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—KRAS—urinary bladder cancer	2.07e-06	2.31e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.07e-06	2.3e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TP53—urinary bladder cancer	2.07e-06	2.3e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.06e-06	2.29e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.04e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.04e-06	2.27e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.98e-06	2.2e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TP53—urinary bladder cancer	1.98e-06	2.2e-05	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—HRAS—urinary bladder cancer	1.98e-06	2.2e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.96e-06	2.18e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.93e-06	2.15e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.92e-06	2.14e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.91e-06	2.13e-05	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—HRAS—urinary bladder cancer	1.89e-06	2.1e-05	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—EP300—urinary bladder cancer	1.82e-06	2.03e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—CDKN1A—urinary bladder cancer	1.82e-06	2.02e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—PTEN—urinary bladder cancer	1.81e-06	2.02e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.81e-06	2.01e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.8e-06	2e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PPARG—urinary bladder cancer	1.79e-06	1.99e-05	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HRAS—urinary bladder cancer	1.76e-06	1.96e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.73e-06	1.92e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—EP300—urinary bladder cancer	1.73e-06	1.92e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—CREBBP—urinary bladder cancer	1.72e-06	1.91e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—SRC—urinary bladder cancer	1.68e-06	1.87e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.61e-06	1.79e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.57e-06	1.74e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.54e-06	1.72e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—PTEN—urinary bladder cancer	1.52e-06	1.69e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.51e-06	1.68e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MYC—urinary bladder cancer	1.51e-06	1.68e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—EGFR—urinary bladder cancer	1.47e-06	1.64e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.46e-06	1.63e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—EP300—urinary bladder cancer	1.45e-06	1.61e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.42e-06	1.58e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTGS2—urinary bladder cancer	1.41e-06	1.57e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.41e-06	1.57e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—KRAS—urinary bladder cancer	1.39e-06	1.55e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.26e-06	1.41e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTEN—urinary bladder cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HRAS—urinary bladder cancer	1.18e-06	1.32e-05	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.18e-06	1.31e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—EP300—urinary bladder cancer	1.17e-06	1.3e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.15e-06	1.28e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.1e-06	1.23e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.08e-06	1.2e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.05e-06	1.17e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—EP300—urinary bladder cancer	1.03e-06	1.14e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1e-06	1.12e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—EP300—urinary bladder cancer	9.58e-07	1.07e-05	CbGpPWpGaD
